Abstract LB544: Targeting adaptive metabolic program as a novel treatment approach for TKIs-failed ALK-positive NSCLCs

作者
You Won Lee,Hun Mi Choi,Seung Yeon Oh,Eun Ji Lee,Kyoung‐Ho Pyo,Jae Hwan Kim,Youngseon Byeon,Seong Gu Heo,Sun Min Lim,Min Hee Hong,Chang Gon Kim,Hye Ryun Kim,Mi Ran Yun,Byoung Chul Cho
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:82 (12_Supplement): LB544-LB544
标识
DOI:10.1158/1538-7445.am2022-lb544
摘要

Abstract Introduction: Acquired resistance to ALK-tyrosine kinase inhibitors (ALK-TKIs) treatment, particularly target-off resistance, remains a clinical challenge for ALK-rearranged non-small cell lung cancer (NSCLC). To explore novel vulnerabilities of ALK TKI-resistant cancer cells, we focused on their distinct metabolic pathways for growth and survival. Experimental Design: To investigate metabolic pathways in resistance mechanisms, we generated ALK-TKIs -acquired-resistant in vitro/vivo models. We screened metabolite mechanisms using metabolite assay kit, Seahorse Extracellular Flux Analyzer, real-time PCR, western blot, RNA-seq in resistant models. Results: Through an integrated transcriptomic and metabolic assay screening approach, we identified the enhanced reliance on glutamine metabolism in target-off ALK-TKIs-resistant cells. Specifically, resistant cells were characterized by upregulation of glutaminase 1 (GLS1), a mitochondrial enzyme hydrolyzing glutamine into glutamate, simultaneously with downregulation of mitochondrial oxidative phosphorylation (OXPHOS). We demonstrated that this metabolic state intensively accelerates glutaminolysis and subsequent mitochondrial glutamine-derived aspartate synthesis, resulting in TKI resistance by reinforcing antioxidant capacity with increase of NADPH and glutathione. Mechanistically, GLS1 inhibition elicited a marked reduction of cell growth with increase of reactive oxygen species (ROS) in resistant cells, which was restored by supplementation of exogenous aspartate. The antitumor activity of GLS1 inhibition against resistant tumor cells was further validated in in vivo experiments, patient-derived xenograft (PDX) and EML4-ALK transgenic mice. More importantly, glutaminase inhibitor CB-839 enhanced the therapeutic efficacy of anti-PD-L1 treatment in immune checkpoint blockade (ICB)-resistant EML4-ALK transgenic mice. Conclusion: Our findings highlight a new metabolic vulnerability of ALK-TKIs resistant tumors and provide a rationale for targeting GLS1 as a potential treatment option to overcome ALK-TKIs resistance. Citation Format: You Won Lee, Hun Mi Choi, Seung Yeon Oh, Eun Ji Lee, Kyoung-Ho Pyo, Jae Hwan Kim, Youngseon Byeon, Seong Gu Heo, Sun Min Lim, Min Hee Hong, Chang Gon Kim, Hye Ryun Kim, Mi Ran Yun, Byoung Chul Cho. Targeting adaptive metabolic program as a novel treatment approach for TKIs-failed ALK-positive NSCLCs [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr LB544.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
枫荧尽染给枫荧尽染的求助进行了留言
1秒前
1秒前
脑洞疼的应助被等风寻梦采纳,获得10
2秒前
下载完成签到,获得积分10
2秒前
3秒前
4秒前
闪闪灵完成签到 ,获得积分10
4秒前
WRZ完成签到 ,获得积分10
4秒前
4秒前
坏坏完成签到,获得积分10
6秒前
6秒前
素龙宝宝发布了新的文献求助10
6秒前
dsfd完成签到,获得积分10
7秒前
7秒前
打打的应助被宝蓝调调采纳,获得10
7秒前
温柔樱桃完成签到 ,获得积分10
8秒前
叶长亭完成签到,获得积分10
9秒前
9秒前
DW的应助被wang采纳,获得10
9秒前
9秒前
9秒前
丘比特的应助被Rbb采纳,获得10
9秒前
梦梦梦发布了新的文献求助10
9秒前
lulu完成签到,获得积分10
9秒前
10秒前
sing完成签到,获得积分10
11秒前
jennawu完成签到 ,获得积分10
11秒前
11秒前
11秒前
12秒前
叶长亭发布了新的文献求助10
12秒前
12秒前
顺利的翠完成签到,获得积分10
12秒前
红雨灰衣完成签到 ,获得积分10
13秒前
18746005898完成签到 ,获得积分10
13秒前
jiang完成签到 ,获得积分10
13秒前
bhsadhusu完成签到 ,获得积分10
14秒前
Xia发布了新的文献求助10
15秒前
共享精神的应助被梦梦梦采纳,获得10
16秒前
激昂的玫瑰完成签到 ,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8168163
求助须知:如何正确求助?哪些是违规求助? 9561243
关于积分的说明 21759855
捐赠科研通 7759477
什么是DOI,文献DOI怎么找? 3429959
关于科研通互助平台的介绍 2553757
邀请新用户注册赠送积分活动 2474496